Long non-coding RNAs and microRNAs (miRNAs) have been reported to participate in the progression of non-small-cell lung cancer (NSCLC). Long intergenic non-protein-coding RNA 472 (LINC00472), miR-149-3p, and miR-4270 were found to be involved in tumor activities, suggesting potential roles in NSCLC. Thus, this study aimed to examine the ability of LINC00472 to influence the progression of NSCLC with the involvement of miR-149-3p and miR-4270. Initially, differentially expressed long non-coding RNAs (lncRNAs), downstream regulatory miRNAs, and genes related to NSCLC were identified. Next, the interaction among LINC00472, miR-149-3p and miR-4270, and KLLN and the p53-signaling pathway was determined. The effect of LINC00472 on the expression of E-cadherin, N-cadherin, and Vimentin was examined through gain-of-function and loss-of-function experiments. Lastly, the effects of LINC00472 on NSCLC tumor growth were assessed in vivo. LINC00472 and KLLN were found to exhibit low levels, while miR-149-3p and miR-4270 were highly expressed in NSCLC. In addition, the overexpression of LINC00472 was observed to upregulate KLLN and activate the p53-signaling pathway, which ultimately inhibited the invasion, migration, and EMT of NSCLC cells via miR-149-3p and miR-4270, corresponding to decreased N-cadherin and Vimentin and increased E-cadherin. The overexpression of LINC00472 exerted an inhibitory effect on tumor growth in vivo. Taken together, the key evidence suggests that the overexpression of LINC00472 can downregulate miR-149-3p and miR-4270 to upregulate KLLN and activate the p53-signaling pathway, thus inhibiting the development of NSCLC. This study highlights the potential of LINC00472 as a promising therapeutic target for NSCLC treatment.
INTRODUCTION
As the foremost form of lung cancer, non-small-cell lung cancer (NSCLC) is the leading cause of death among men and women worldwide, which accounts for about 80% to 85% of all patients with lung cancer. 1, 2 The epithelial-mesenchymal transition (EMT) is a pivotal event in epithelial-derived cancers during tumor invasion and metas-tasis, which was also found to participate in the progress of NSCLC. 3 The EMT is characterized by the altered expression of epithelial and mesenchymal markers, in addition to morphological changes. 4 At present, surgical resection represents the most common treatment as well as the gold standard for NSCLC treatment; however, the prognosis for patients with advanced NSCLC remains poor, owing largely to post-surgical recurrence rates, which chiefly depend on the final pathological stage. 5 The finer details associated with the metastatic mechanism of NSCLC are yet to be fully understood, highlighting the need for better prognostic markers for NSCLC. Accumulating evidence has illustrated that long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) play a role in the development of NSCLC. [6] [7] [8] lncRNAs represent a class of RNAs that are over 200 nt with limited or no protein-coding capacity, which have been implicated in a large variety of biological processes, such as transcriptional regulation, cell growth, and tumorigenesis. 9, 10 It was demonstrated that the expression of long intergenic non-protein-coding RNA 472 (LINC00472) can be utilized as a marker of breast cancer, with high expression levels of LINC00472 reported to be indicative of better disease outcome. 11 A microarray-based gene expression analysis was performed during the current study, which predicted that LINC00472 was downregulated and miR-149-3p and miR-4270 were upregulated in NSCLC. miR-149-3p has been found to promote cancer proliferation and motility via the coordinated suppression of tumor suppressor Disabled-2 Interacting Protein in the stromal and tumor cells. 12 The existing literature has suggested that miR-4270 is highly expressed in highly metastatic gastric cancer cells, highlighting its potential as a tumor contributor in gastric cancer. 13 Moreover, the microarraybased gene expression analysis also revealed that miR-149-3p and miR-4270 could directly bind to killin (KLLN). Data obtained revealed that KLLN could stimulate the expression of p53 and p73 in the form of transcription and, thus, inhibit tumor cell growth and enhance cell apoptosis. 14 A previous study has asserted that the p53-signaling pathway is downregulated in lung cancer tissues in vitro, highlighting the role of the p53-signaling pathway in lung cancer cell activities. 15 Hence, the current study aimed to investigate the mechanism by which LINC00472, miR-149-3p, miR-4270, KLLN, and the p53-signaling pathway regulate the EMT and invasion as well as the metastasis of NSCLC cells.
RESULTS

Low Expression Level of LINC00472 Is Observed in NSCLC
The GEO database was explored to retrieve the NSCLC-related microarray data. Differential expression analysis of lncRNAs in NSCLC samples and normal control samples in the microarray data was performed. Finally, 1,029 significantly differentially expressed lncRNAs were obtained from the microarray data. Among the differentially expressed lncRNAs, 4 lncRNAs exhibited significant differences. Among these 4 lncRNAs, we identified that LINC00472 was significantly downregulated in NSCLC and its downregulation was the most significant among the four lncRNAs ( Figures 1A and 1B) . To verify the predicted results of the microarray-based gene expression analysis, the expression of LINC00472 in 119 cases of human NSCLC tissues and adjacent normal tissues was detected by qRT-PCR ( Figure 1C) , the results of which demonstrated that the expression of LINC00472 was markedly downregulated in NSCLC tissues when compared to adjacent normal tissues (p < 0.05). qRT-PCR was adopted to detect the relative expression of LINC00472 in NSCLC cell lines (NCI-H838, NCI-H1975, NCI-H157, NCI-H358, and NCI-H1299) and human normal lung epithelial cell line (BEAS-2B) ( Figure 1D ). The results revealed that, compared with BEAS-2B cells, the expression of LINC00472 in the aforementioned five human NSCLC cell lines was considerably downregulated, with the decline more pronounced in NCI-H1299 cells (p < 0.05).
The application of a Kaplan-Meier curve was used to analyze the association between LINC00472 and the disease prognosis in NSCLC patients ( Figure 1E ). The mean value of LINC00472 expression was set as the cutoff point, based on which the patients were segregated into the high-expression group (R0.432) and low-expression group (<0.432). The results obtained revealed that the low expression of LINC00472 was associated with poor prognosis among NSCLC patients. The subcellular localization of LINC00472 in NCI-H1299 cells was detected by RNA-fluorescence in situ hybridization (FISH) assay ( Figure 1F ), the results of which revealed that the expression of LINC00472 was predominantly in the cytoplasm and nucleus of the NCI-H1299 cells. The aforementioned results revealed that LINC00472 was lowly expressed in the NSCLC cells and mainly located in the cytoplasm and nucleus of the NCI-H1299 cell.
Overexpression of LINC00472 Inhibits the Proliferation, Migration, Invasion, and EMT of NCI-H1299 Cells
Microarray-based gene expression analysis revealed that LINC00472 was lowly expressed in NSCLC, which led us to investigate the effects associated with the overexpression of LINC00472 on the biological properties of NSCLC NCI-H1299 cells. The plasmid transfection efficiency in the overexpression (oe)-LINC00472 group was detected by qRT-PCR ( Figure 2A ). The results obtained suggested that the expression of LINC00472 in the oe-LINC00472 group was significantly higher than that in the oe-negative control (NC) group (p < 0.05), and the transfection efficiency met the requirements for further experiments. Western blot analysis was adopted to determine the expressions of EMT-related epithelial marker (E-cadherin) and interstitial markers (N-cadherin and Vimentin) ( Figure 2B) . The results demonstrated that, compared with the oe-NC group, the expression of E-cadherin was significantly increased, while the expressions of N-cadherin and Vimentin were significantly decreased in the oe-LINC00472 group (p < 0.05).
The 5-ethynyl-2 0 -deoxyuridine (EdU) and Transwell assays were employed to evaluate the cell proliferation, migration, and invasion ( Figures 2C and 2D ), which displayed that the cell proliferation, migration, and invasion were significantly reduced in the oe-LINC00472 group compared with the oe-NC group (all p < 0.05).
The aforementioned results suggested that upregulated LINC00472 could suppress the proliferative, migration, invasion, and EMT abilities of the NSCLC cells.
Knockdown of LINC00472 Promotes the Proliferation, Migration, Invasion, and EMT of NCI-H1299 Cells
To further elucidate the role by which LINC00472 influences the NCI-H1299 cell proliferation, migration, invasion, and EMT, NCI-H1299 cells were transfected with short hairpin (sh)-LINC00472, with sh-NC as the control. Initially, the efficiency of plasmid transfection in the sh-LINC00472 group was evaluated by the qRT-PCR method ( Figure 3A ). The results demonstrated that the expression of LINC00472 in the sh-LINC00472 group was markedly lower than that in the sh-NC group (p < 0.05), indicating the transfection efficiency met the requirement for further experiments.
Next, the quantification of EMT-related markers was determined by western blot analysis ( Figure 3B ), which revealed a marked decline in the expression of E-cadherin in the sh-LINC00472 group, while remarkably stimulated expression levels of N-cadherin and Vimentin were detected in comparison to the findings in the sh-NC group (all p < 0.05). Additionally, cell proliferation, migration, and invasion were detected by EdU and Transwell assays, respectively ( Figures  3C and 3D ). The findings revealed that cell proliferation, migration, and invasion in the sh-LINC00472 group were significantly elevated relative to those in the sh-NC group (all p < 0.05). Taken together, the aforementioned results suggested that LINC00472 silencing could contribute to the potentiated proliferation, migration, invasion, and EMT of NCI-H1299 cells.
Overexpression of LINC00472 Upregulates KLLN through Inhibiting the miR-149-3p and miR-4270 Expressions in NCI-H1299 Cells
To further obtain the downstream regulatory mechanism of LINC00472, the RNA22 database was explored to predict the potential downstream regulatory miRNAs of LINC00472. At the same time, a miRNA expression microarray dataset, GEO: GSE53882, of NSCLC was obtained. A differential expression analysis of GEO: GSE53882 revealed a significant upregulation in the expression of 104 miRNAs in NSCLC samples. An intersection of the two miRNA datasets (Figure 4A ) indicated that a total of 39 miRNAs were intersected, which confirmed that these 39 miRNAs were highly likely to function as downstream regulatory miRNAs of LINC00472 in NSCLC.
Among the 39 miRNAs, miR-4270 exhibited a notably high expression pattern in NSCLC (Table S1 ). The prediction of the downstream target genes of miRNAs demonstrated that both miR-149-3p and miR-4270 were upregulated in NSCLC and were capable of regulating the expression of KLLN. Thus, we predicted that LINC00472 was likely to regulate both miR-149-3p and miR-4270, which further modulated the expression of their common target gene KLLN and affected the development of NSCLC. The biological prediction website (https://cm.jefferson.edu/rna22/Interactive/) was employed to determine the existence of binding sites between LINC00472 and miR-149-3p as well as miR-4270. The biological prediction website www.moleculartherapy.org (http://www.mirbase.org/) was explored to determine whether both miR-149-3p and miR-4270 have binding sites with KLLN ( Figure 4B ).
The expressions of miR-149-3p and miR-4270 in the tissues and cells were measured by qRT-PCR ( Figure 4C ), the results of which showed that miR-149-3p and miR-4270 were upregulated in NSCLC cells and tissues (p < 0.05). Besides, miR-149-3p and miR-4270 were both found to be negatively correlated with the expression of LINC00472 ( Figure 4D ). Subsequently, we confirmed that LINC00472 negatively regulated the expression of miR-149-3p and miR-4270 and positively regulated KLLN ( Figure 4E ). Furthermore, miR-149-3p and miR-4270 in turn negatively regulated the expression of KLLN ( Figure 4F ).
A dual-luciferase reporter gene assay was adopted to determine the fluorescence intensity of the NC mimic, miR-149-3p mimic, and miR-4270 mimic respectively co-transfected with wild-type (WT)-LINC00472, mutant-type (mut)-LINC00472, WT-KLLN, and mut-KLLN ( Figure 4G ). The results obtained suggested that, compared with the NC mimic group, the fluorescence intensity was significantly decreased after miR-149-3p mimic and miR-4270 mimic were respectively co-transfected with WT-LINC00472 and WT-KLLN (p < 0.05), while no significant difference was detected regarding the fluorescence intensity after miR-149-3p mimic and miR-4270 mimic were respectively co-transfected with mut-LINC00472 and mut-KLLN (p > 0.05). The RNA-binding protein immunoprecipitation (RIP) assay results revealed that miR-149-3p and miR-4270 could bind to LINC00472 or KLLN ( Figure 4H ). mimic + oe-NC group or the miR-4270 mimic + oe-NC group, the expression of KLLN was significantly increased in the miR-149-3p mimic + oe-LINC00472 group or miR-4270 mimic + oe-LINC00472 group (both p < 0.05). Taken together, the above results provide evidence suggesting that overexpressed LINC00472 could upregulate the expression of KLLN by inhibiting the expression of miR-149-3p and miR-4270.
Overexpression of LINC00472 Reduces the EMT, Migration, and Invasion of NCI-H1299 Cells through Sponging miR-149-3p and miR-4270
To evaluate the combined effects of LINC00472 and miR-149-3p or miR-4270, the mRNA and protein expressions of EMT-associated epithelial marker (E-cadherin) and interstitial markers (N-cadherin and Vimentin) in NCI-H1299 cells were evaluated accordingly by qRT-PCR and western blot analysis ( Figure 5A ). The results revealed that, compared to the NC mimic group, the expression of E-cadherin in the miR-149-3p mimic or miR-4270 mimic groups notably diminished (both p < 0.05), while the expressions of N-cadherin and Vimentin were markedly elevated (both p < 0.05). Compared to the miR-149-3p mimic + oe-NC group or the miR-4270 mimic + oe-NC group, the miR-149-3p mimic + oe-LINC00472 group or the miR-4270 mimic + oe-LINC00472 group distinctly promoted expression levels of E-cadherin (both p < 0.05), while significantly diminished expressions of N-cadherin and Vimentin were identified (both p < 0.05).
Similarly, cell proliferation, migration, and invasion assessed by EdU and Transwell assays ( Figures 5B-5D ) revealed that, compared with the NC mimic group, miR-149-3p mimic or miR-4270 mimic treatment led to enhanced cell proliferation, migration, and invasion (all p < 0.05). However, the addition of oe-LINC00472 was found to be capable of rescuing miR-149-3p mimic-or miR-4270 mimic-induced stimulation of proliferation, invasion, and migration relative to that of oe-NC (all p < 0.05). These results suggest that the proliferation, invasion, migration, and EMT of NCI-H1299 cells could be hindered by miR-149-3p-or miR-4270-dependent LINC00472 overexpression.
Overexpression of LINC00472 Activates the p53-Signaling Pathway and Inhibits the EMT, Migration, and Invasion of NCI-H1299 Cells through Upregulating the Expression of KLLN
A gene interaction network map was constructed based on the correlation analysis between KLLN and the known genes related to NSCLC retrieved from the DisGeNET database ( Figure 6A ). Evidence was obtained suggesting that only the KLLN gene interacted with known genes related to NSCLC, among which the direct regulation of TP53 by KLLN has been previously validated. 16 Meanwhile, the TP53 gene was at the core of the p53-signaling pathway (map: 04115), and the TP53 gene and the p53-signaling pathway were identified to play a role in the progression of various neoplastic diseases. [17] [18] [19] [20] The immunohistochemistry results demonstrated (Figure 6B ) that the expression of KLLN was significantly lower in NSCLC tissues than in adjacent normal tissues (p < 0.05). Besides, the qRT-PCR results suggested ( Figure 6C ) that, relative to the normal lung epithelial cell line (BEAS-2B), the expression of KLLN was also remarkably decreased in the NSCLC cell line NCI-H1299 (p < 0.05). We detected that LINC00472 was positively correlated with KLLN expression, based on our correlation analysis ( Figure 6D ).
Next, NCI-H1299 cells were co-transfected with oe-LINC00472 and sh-NC or sh-KLLN, and the transfection efficiency was detected by qRT-PCR ( Figure 6E) . Compared with the oe-NC + sh-NC group, the transfection efficiencies of the oe-LINC00472 + sh-NC group and the oe-LINC00472 + sh-KLLN group met the requirements for further experiments (p < 0.05). The qRT-PCR and western blot analysis were employed to evaluate the expression of p53, p21, as well as the epithelial markers (E-cadherin) and interstitial markers (N-cadherin and Vimentin) related to the EMT ( Figure 6F ). Compared with the oe-NC + sh-NC group, the expressions of p53, p21, and E-cadherin in the oe-LINC00472 + sh-NC group were significantly increased, while those of N-cadherin and Vimentin were notably decreased (all p < 0.05); the expressions of p53, p21, and E-cadherin in the oe-LINC00472 + sh-KLLN group were significantly decreased, while the expressions of N-cadherin and Vimentin were significantly increased (all p < 0.05).
Cell proliferation, migration, and invasion were detected by EdU and Transwell assays ( Figures 6G and 6H) , the results of which revealed that, compared with the oe-NC + sh-NC group, the cell proliferation, migration, and invasion were remarkably decreased in the oe-LINC00472 + sh-NC group (all p < 0.05), while the cell proliferation, migration, and invasion in the oe-LINC00472 + sh-KLLN group were evidently increased (all p < 0.05). The aforementioned results provided confirmation indicating that the overexpression of LINC00472 activates the p53-signaling pathway and further inhibits the EMT, migration, and invasion of NSCLC cells via the upregulation of KLLN expression.
Overexpression of LINC00472 Inhibits Tumor Formation and Growth of NSCLC Cells In Vivo
In an attempt to validate the effect associated with LINC00472 on the development of tumor xenografts in vivo, the nude mice were assigned to the oe-NC group and the oe-LINC00472 group. The tumor xenograft in nude mice experiment ( Figure 7A ) indicated that, compared with the oe-NC group, the mean volume of tumor xenografts in the oe-LINC00472 group was significantly reduced (p < 0.05). qRT-PCR was adopted to measure the expressions of LINC00472, miR-149-3p, and miR-4270 in tumor xenografts in the two groups ( Figure 7B) , the results of which demonstrated that the expression of LINC00472 was significantly increased in the oe-LINC00472 group when compared to the oe-NC group (p < 0.05), while the expressions of miR-149-3p and miR-4270 were significantly decreased (p < 0.05).
Next, the expressions of KLLN, E-cadherin, N-cadherin, Vimentin, p21, p53, and cyclin D1 in the two groups were detected by immunohistochemistry ( Figure 7C ), the results of which revealed that, compared with the oe-NC group, the expressions of KLLN, www.moleculartherapy.org E-cadherin, p53, and p21 were significantly upregulated in the oe-LINC00472 group (p < 0.05), while those of N-cadherin, Vimentin, and cyclin D1 were remarkably decreased (p < 0.05). The above results provided evidence suggesting that high LINC00472 expression inhibits the development of NSCLC cells in vivo.
DISCUSSION
NSCLC remains one of the foremost malignancies afflicting the lungs, and it is characterized by rapid growth and aggressive features during its progression, leading to a large number of deaths on an annual basis worldwide. 21 Recent reports have indicated that LINC00472 assumes www.moleculartherapy.org a tumor-suppressive role in various types of cancers, including gastric cancer, epithelial ovarian cancer, and colorectal cancer. [22] [23] [24] However, the role of LINC00472 functioning in NSCLC has remained largely unknown. The results obtained during our study suggested that the overexpression of LINC00472 upregulated the expression of KLLN and further activated the p53-signaling pathway, resulting in the suppression of migration, invasion, and the EMT of NSCLC cells by inhibiting the expressions of miR-149-3p and miR-4270.
Our initial observations revealed that LINC00472 and KLLN were lowly expressed while miR-149-3p and miR-4270 were highly expressed in NSCLC. Interestingly, consistent with our findings, a previous study using a lncRNA-mediated competing endogenous RNA (ceRNA) network investigated potential lncRNA biomarkers in lung adenocarcinoma, and it concluded that LINC00472 was downregulated in lung adenocarcinoma tissues. 25 Several lncRNAs have been highlighted due to their tumor-suppressive abilities in NSCLC. For example, the expression of lncRNA-p21 expression has been demonstrated to be lower in NSCLC tissues when compared to paired normal tissues, suggesting that increased levels of lncRNA-p21 are associated with longer overall and disease-free survival of NSCLC patients. 26 The expression level of lncRNA HMlincRNA717 was also found decreased in NSCLC tissues, and HMlincRNA717 was suggested as the therapeutic target in the treatment of patients with NSCLC. 27 The existing literature has presented evidence illustrating that KLLN is downregulated in breast cancer, suggesting that it plays a tumor suppressor role in breast cancer. 16 A study analyzed miR-149-3p expression in data obtained from The Cancer Genome Atlas (TCGA) consortium, and it found that miR-149-3p was upregulated in human malignancies, including lung cancer. 12 Furthermore, miR-4270 has been found to be upregulated in immune thrombocytopenic purpura and sepsis-induced acute kidney injury, in addition to displaying upregulated levels in gastric cancer and breast cancer patients. 13, [28] [29] [30] Next, it has been shown that LINC00472 competitively bound to both miR-149-3p and miR-4270, which could target KLLN to regulate the p53-signaling pathway in NSCLC. LINC00472 as a tumor suppressor in colorectal cancer cells has been proven to bind to miR-196a and play a crucial role in the ceRNA regulatory network. 24 KLLN, as a target gene of miR-224, functions as proto-oncogene or anti-onco-gene in various types of cancer cells. 31 Gene correlation analysis demonstrated the existence of a strong correlation between KLLN and the TP53 gene, which is involved in the progression of tumors associated with the p53-signaling pathway. 17, 19 Wang et al. 14 concluded that KLLN could upregulate the expression of TP53 and TP73, which ultimately acts to promote cell apoptosis in prostate cancer. Besides, the overexpression of lncRNA MEG3 inhibits the proliferation and metastasis of gastric cancer by activating the p53signaling pathway. 32 In the subsequent assays, we found that over-regulation of LINC00472 downregulated miR-149-3p and miR-4270 to inhibit the invasion, migration, and EMT of NSCLC cells, corresponding to the high expression of E-cadherin and low expressions of N-cadherin and Vimentin. Consistently, it has been confirmed that overexpressed LINC00472 is capable of suppressing the proliferation while stimulating apoptosis through regulating miR-24-3p in lung adenocarcinoma cells, which may be a potential biomarker and therapeutic target for lung adenocarcinoma. 33 Another lncRNA, LINC01186, has been suggested to inhibit the migration and invasion of lung cancer cells by mediating the transforming growth factor b (TGF-b)-signaling pathway. 34 In the current study, LINC00472 was demonstrated to inhibit NSCLC cell EMT, migration, and invasion by upregulating the expression of KLLN. LINC01133 has been indicated to suppress colorectal cancer through the inhibition of tumor cell metastasis and EMT, corresponding to upregulated levels of E-cadherin and downregulated Vimentin. 35 Furthermore, based on an in vivo assay, evidence has been presented demonstrating that the upregulation of LINC00472 inhibited the tumor growth of NSCLC.
Based on our in vitro and in vivo experiments, we obtained data indicating that the overexpression of LINC00472 upregulates KLLN to inhibit the proliferation, invasion, and EMT of NSCLC cells through the downregulation of miR-149-3p and miR-4270 ( Figure 8 ). We uncovered encouraging data that placed further emphasis on the value of LINC00472 as a potential novel therapeutic target for NSCLC. Nevertheless, due to the limited cases and lack of clinical value development, the effectiveness of our findings from a clinical perspective will be confirmed in the future by a large-sample, multicenter, and randomized controlled trial. 
MATERIALS AND METHODS
Ethics Statement
All experimental protocols were performed with the approval of the ethics committee of the Affiliated Hospital of Guangdong Medical University. Informed written consent was obtained from each patient.
All animal experiments were in line with the Guide for the Care and Use of Laboratory Animal by International Committees. Extensive efforts were made to ensure minimal suffering of the animals used during the study.
Microarray-Based Gene Expression Analysis
The GEO database (https://www.ncbi.nlm.nih.gov/geo/) was retrieved to obtain the microarray data of NSCLC. The R-language limma package was utilized for differential expression analysis. The expression of LINC00472 in the cells was obtained from the lncATLAS database (http://lncatlas.crg.eu/). The downstream miRNAs of LINC00472 and target genes of miRNAs were predicted by the RNA22 database (https://cm.jefferson.edu/rna22/). The known NSCLC-related disease genes were obtained from the DisGeNET database (http://www.disgenet.org/), with the correlation analysis between the candidate target genes of miRNAs as well as the known disease genes performed by the STRING database (https://string-db. org/). Finally, the p53-related-signaling pathway was retrieved by the Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway database (https://www.kegg.jp/kegg/pathway.html).
Sample Collection and Cell Culture
A total of 119 fresh frozen NSCLC tissue specimens as well as corresponding adjacent normal tissue specimens was collected from patients who had previously undergone a surgical procedure at the Affiliated Hospital of Guangdong Medical University between June 2017 and July 2018. All patients were followed up for 5 years, with a follow-up rate of 97.47% (116/119). Five NSCLC cell lines, NCI-H838, NCI-H1975, NCI-H157, NCI-H358, and NCI-H1299 cells, and human normal lung epithelial cell line (BEAS-2B) were purchased from the National Experimental Cell Resource Sharing Platform (http://www.cellresource.cn/). The cells were incubated in DMEM (Gibco, Carlsbad, CA, USA) complete medium containing 10% fetal bovine serum (FBS), 100 mg/mL streptomycin, and 100 U/mL penicillin in an incubator with 5% CO 2 and 95% saturated humidity at 37 C. Cell passage was performed when cell growth density reached approximately 90%. The qRT-qPCR was employed to determine the expression of LINC00472 in these five NSCLC cell lines, with the cell line exhibiting the lowest LINC00472 expression being screened out for subsequent experiments.
Cell Transfection
NSCLC cells were transfected with plasmids of oe-NC, oe-LINC00472, sh-NC, sh-LINC00472, NC inhibitor, miR-149-3p inhibitor, miR-4270 inhibitor, NC mimic, miR-149-3p mimic, miR-149-3p mimic + oe-NC, and miR-149-3p mimic + oe-LINC00472; and NC mimic, miR-4270 mimic, miR-4270 mimic + oe-NC, miR-4270 mimic + oe-LINC00472, oe-NC + sh-NC, oe-LINC00472 + sh-NC, and oe-LINC00472 + sh-KLLN. All target plasmids were pur-chased from Dharmacon (Lafayette, CO, USA). The cell density was adjusted according to the cell growth rate, and the cells were seeded in a 6-well plate to reach a confluence of 80%-90% on the second day of transfection. The Lipofectamine 2000 kit (Invitrogen, Carlsbad, CA, USA) was employed for cell transfection, in accordance with the protocols provided by the manufacturer. Next, 250 mL Opti-MEM medium (Gibco, Carlsbad, CA, USA) was used to dilute 4 mg target plasmid and 10 mL Lipofectamine 2000 accordingly. After thorough mixing and reservation for 5 min at room temperature, the two diluted solutions were uniformly mixed together and allowed to stand for another 20 min. The mixture of Lipofectamine 2000 as well as the plasmids was subsequently added to the wells coated with cells. After 8 h of transfection, fresh medium was replaced for an additional 48-h period of incubation for a subsequent experiment.
RNA Isolation and Quantitation
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) and reversely transcribed into cDNA using the reverse transcription kit (RR047A, Takara Bio, Otsu, Shiga, Japan). The SYBR Premix EX Taq kit (RR420A, Takara Bio, Otsu, Shiga, Japan) was applied for sample loading, and the samples were subjected to qPCR in a real-time fluorescence qPCR (ABI7500, Applied Biosystems, Foster City, CA, USA). Three replicate wells were set for each sample. All primers (Table 1) were synthesized by Shanghai Sangon Biological Engineering Technology & Services (Shanghai, China). The Ct value of each well was recorded, with U6 serving as the internal control for miR-149-3p and miR-4270, while glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was regarded as the internal control for the other genes. The relative expression of the product was calculated based on the 2 ÀrrCt method.
FISH
The subcellular localization of LINC00472 was identified through FISH assay, as per the instructions of Ribo lncRNA FISH Probe Mix (Red) (C10920, RiboBio, Guangzhou, Guangdong, China). The cell slides were placed in a 24-well culture plate, and cells were inoculated at a density of 6 Â 10 4 cells/well, so that the cell confluence reached 60%-70%. The cells were then fixed at room temperature for 10 min with 1 mL 4% polyformaldehyde and washed accordingly.
After that, the cells in each well were permeabilized at 4 C for 5 min with 1 mL pre-cooled 0.5% Triton X-100 in PBS. The cells in each well were then blocked with 200 mL pre-hybridization solution at 37 C for 30 min. After removal of the pre-hybridization solution, probe hybridization solution containing anti-LINC00472 nucleotide probe (Wuhan Genecreate Bioengineering, Wuhan, Hubei, China) was added to hybrid overnight at 37 C under dark conditions. The following steps were all conducted under conditions void of light. The cells were washed 3 times in a successive manner using washing buffer I (4 Â standard saline citrate [SSC] containing 0.1% Tween-20), washing buffer II (2 Â SSC), washing buffer III (1 Â SSC), and 1 Â PBS respectively (5 min each time). The cells were stained with DAPI staining solution diluted at a ratio of 1:800 for 10 min, washed, and sealed with nail polish. Finally, 5 different views were selected and analyzed under a fluorescence microscope (Olympus Optical, Tokyo, Japan) with images subsequently obtained.
Immunohistochemistry
The tissue sections were placed in a 60 C incubator for 1 h, dewaxed by conventional xylene, hydrated with gradient ethanol, incubated with PBS containing 0.5% Triton for 20 min at room temperature, and washed 2-3 times with PBS (5-10 min each time). After being repaired for 2 min with high-pressure antigen, the sections were boiled at 95 C for 20 min in 0.01 M citric acid buffer (pH 6.0), immersed in 3% H 2 O 2 for 15 min to block the exogenous peroxidase activity, and sealed with 3% BSA at 37 C for 20-30 min. The sections were subsequently incubated with the primary antibodies, rabbit anti-human antibodies against KLLN (ab221907, 1:500), E-cadherin (ab15148, 1:30), N-cadherin (ab18203, 1:100), Vimentin (ab8978, 1:80), p53 (ab131442, 1:50), Ki67 (ab15580, 1:100), and matrix metalloproteinase-9 (MMP-9) (ab38898, 1:100), for 2 h at 37 C and rinsed with PBS. Following PBS aspiration, the sections were incubated with the secondary antibody, goat anti-rabbit antibody against immunoglobulin G (IgG) labeled with horseradish peroxidase (HRP; ab6721, 1:1,000), at 37 C for 30 min in a wet box. All the aforementioned antibodies were purchased from Abcam (Cambridge, MA, USA).
The sections were then counterstained with hematoxylin (Shanghai Fusheng Industrial, Shanghai, China) at room temperature for 4 min. The section was then mounted with 10% glycerol and PBS and observed under the microscope. The immunohistochemistry results were scored independently by two individuals using the doubleblinded method. The experiment was repeated three times.
RIP Assay
The cultured cells were washed twice with cold PBS, added to 10 mL PBS, and transferred into a centrifuge tube. The cells were centrifuged at 1,500 rpm for 5 min at 4 C, after which the supernatant was discarded. The cells were then lysed with 100 mL RIP lysis buffer (N653, Shanghai Haoran Biological Technology, Shanghai, China) on ice for 5 min to obtain the cell lysate. Next, 50 mL magnetic beads was added in each tube, and 0.5 mL RIP wash buffer (EHJ-BVIS08102, Xiamen Huijia Biotechnology, Xiamen, Fujian, China) was added. The beads were washed, re-suspended with 100 mL RIP wash buffer in each tube, followed by the addition of 5 mg argonaute 2 (Ago2) antibody (P10502500, Shenzhen Otwo Biotechnology, Shenzhen, Guangdong, China). The normal mouse antibody to IgG was regarded as the NC, incubated for 30 min at room temperature followed by discarding of the supernatant. The magnetic beads were washed twice with 0.5 mL RIP wash buffer for the subsequent experiment.
Next, 900 mL RIP immunoprecipitation buffer (P10403138, Shenzhen Otwo Biotechnology, Shenzhen, China) was added to the magnetic bead-antibody complexes, after which the cell lysate was centrifuged at 14,000 rpm for 10 min at 4 C. The supernatant was transferred into a new eppendorf (EP) tube (LBCT015S, Beijing North TZ-Biotech Develop, Beijing, China), with 100 mL supernatant transferred into the tube containing magnetic bead-antibody complexes with 1.0 mL as the final volume of the immunoprecipitation reaction. The tubes were subsequently incubated overnight at 4 C, with the magnetic beads washed 6 times with 0.5 mL RIP wash buffer. The RNA was purified with 150 mL proteinase K buffer for 30 min at 55 C. RNA extraction was performed based on the conventional TRIZOL method, followed by detection by means of qRT-PCR.
Western Blot Analysis
The total protein in tissues or cells was extracted by means of radioimmunoprecipitation assay lysis buffer containing phenylmethylsulfonyl (PMSF). The protein was incubated on ice for 30 min at 4 C, and it was centrifuged at 8,000 Â g for 10 min to collect the supernatant. The total protein concentration was measured using a bicinchoninic acid (BCA) kit. Then, 50 mg protein was dissolved in 2 Â SDS loading buffer. After boiling at 100 C for 5 min, the protein was separated by SDS-PAGE. The protein was transferred onto a polyvinylidene fluoride (PVDF) membrane via the wet transfer method, followed by blockade with 5% skim milk powder at room temperature for 1 h. The PVDF membrane was incubated with the primary antibodies, rabbit anti-human antibodies to KLLN (ab197892, 1:500), E-Cadherin (ab15148, 1:500), N-Cadherin (ab76057, 1:1,000), Vimentin (ab92547, 1:2,000), p53 (ab131442, 1:500), and GAPDH (internal reference; ab9485, 1:2,500), overnight at 4 C. The membrane was incubated with the secondary antibody, HRP-labeled goat anti-rabbit IgG (ab97051, 1:2,000), for 1 h and rinsed with Trisbuffered saline with Tween (TBST). All the aforementioned antibodies were purchased from Abcam (Cambridge, MA, USA).
Solution A and solution B from an enhanced chemiluminescence (ECL) fluorescence detection kit (BB-3501, Amersham Pharmacia Biotech, Piscataway, NJ, USA) were mixed under conditions void of light, followed by dropwise addition onto the membrane, with a gel imager then employed for exposure. The Bio-Rad image analysis system (Bio-Rad, Hercules, CA, USA) was used for image collection, after which Quantity One version (v.)4.6.2 software was utilized for analyses. The relative protein expression was expressed as the gray value of the corresponding protein band to the gray value of the GAPDH protein band. The experiment was repeated three times, and the average value obtained was selected accordingly.
Dual-Luciferase Reporter Gene Assay
The WT and mut reporter plasmids of LINC00472 (WT-LINC00472 and mut-LINC00472) and the WT and mut reporter plasmids of KLLN (WT-KLLN and mut-KLLN) were provided by Shanghai GenePharma (Shanghai, China). The NC mimic, miR-149-3p mimic, and miR-4270 mimic were respectively co-transfected with WT-LINC00472, mut-LINC00472, WT-KLLN, and mut-KLLN into 293T cells. The cells were cultured for 48 h, with the changes in luciferase activity measured based on the instructions of the dual-luciferase reporter gene assay kit (D0010, Beijing Solarbio Technology, Beijing, China). The fluorescence intensity was detected using GLomax 20/20 Luminometer (E5311, Shaanxi Zhongmei Biotechnology, Xi'an, Shaanxi, China). The experiment was repeated three times.
EdU Fluorescence Assay
Cells at the logarithmic growth phase were seeded in the 96-well plates at a density of 5 Â 10 4 cells/well. After adherence to the wells, the cells in each well were incubated for 2 h in 500 mL EdU medium (50 mmoL/L), fixed with 40 g/L paraformaldehyde for 20 min, incubated with 2 mg/mL glycine for 10 min, and washed twice with PBS. Later, the cells were permeabilized with 500 mL 0.5% Triton, and they were permitted to react with Apollo staining solution for 0.5 h under dark conditions, followed by two PBS washes. Afterward, the cells were incubated with Hoechst 33342 reaction solution for 0.5 h under dark conditions, washed twice with 0.5% Triton, and observed under an inverted fluorescence microscope. The professional image analysis software Image-Pro Plus 6.0 was applied to count the cell number.
Transwell Assay
The pre-cooled Matrigel (40111ES08, Shanghai Yeasen Biotechnology, Shanghai, China) diluted with serum-free DMEM at the ratio of 1:8 was used to coat the Transwell apical chamber (3413, Beijing Unique Biotech, Beijing, China) (the step could be ignored in the migration experiment), and it was solidified in a 37 C incubator for 4-5 h. The transfected cells were diluted with 100 mL serum-free medium to prepare a cell suspension at a concentration of about 1 Â 10 6 cells/mL. Later, the cells were inoculated, and 500 mL DMEM containing 20% FBS was added to the basolateral chamber, with 3 replicate wells in each group. The cells were incubated for 24 h at 37 C with 5% CO 2 . The transwell chamber was washed twice with PBS, fixed with 5% glutaraldehyde at 4 C, stained with 0.1% crystal violet for 5 min, followed by two additional PBS washes. The cells on the surface were wiped with cotton balls. After that, they were analyzed under an inverted fluorescence microscope (TE2000, Nikon Imaging Sales, Shanghai, China). Five fields were randomly selected for photographing (200Â), with the mean value selected as the number of cells passing through the chamber in each group. The experiment was repeated three times.
Tumor Formation in Nude Mice
A total of 12 BALA/c nude mice (without limitation in gender, aged 4 weeks, weighing 18-22 g) was purchased from Guangdong Medical Laboratory Animal Center (Foshan, Guangdong, China) (http://www. gdmlac.com.cn/). The mice were placed in a controlled specific pathogen-free (SPF) environment and randomly divided into two groups (6 mice for each group). The cell lines with stable transfection of oe-NC and oe-LINC00472 were screened and subcutaneously injected into the mice at 1 Â 10 6 NCI-H1299 cells/mouse. The data were recorded on the seventh, 14 th , 21 st , and 28 th days after inoculation. The nude mice were euthanized by means of carbon dioxide asphyxiation following completion of the experiment. The volume calculation formula of the tumor xenograft was as follows: V (mm 3 ) = (A Â B 2 )/2 where A is the long diameter and B is the short diameter, and the average volume graph at each time point was plotted.
Statistical Analysis
All experimental data statistical analyses were conducted by SPSS 21.0 software (IBM, Armonk, NY, USA). All experiments were repeated three times. Normality and homogeneity of variance were evaluated and confirmed in all the data. Measurement data were expressed as mean ± SD. Paired t test was employed for comparison between the experimental data of NSCLC tissues and adjacent normal tissues. Other comparisons between two groups were analyzed by means of an unpaired t test. Comparisons among multiple groups were analyzed by one-way ANOVA. Pairwise comparison among multiple groups was performed using a post hoc test. Data at different time points were compared by repeated-measure ANOVA. Kaplan-Meier analysis was conducted for survival of NSCLC patients with high or low expression of LINC00472. The correlation of miR-149-3p and miR-4270 with LINC00472 was assessed through Pearson correlation analysis. p < 0.05 was considered to be indicative of a statistically significant difference.
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